Quantitative risk assessment for developmental neurotoxic effects

Risk Analysis

Volumn 24, Issue 6, 2004, Pages 1673-1681

  Razzaghi, Mehdi ^a   Kodell, Ralph ^b  

^a BLOOMSBURG UNIVERSITY   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Benchmark dose; Developmental neurotoxicity; Dose response; Likelihood ratio; Risk assessment

Indexed keywords

BIOASSAY; BRAIN; DATA REDUCTION; HEALTH; PROBABILITY; RISK ASSESSMENT; STATISTICAL METHODS; TOXICITY;

ASYMPTOTIC DISTRIBUTIONS; DOSE-RESPONSE MODEL; NEURODEVELOPMENT; NEUROTOXIC EFFECTS;

NEUROLOGY;

TOXICITY;

ANIMAL EXPERIMENT; ARTICLE; CALCULATION; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; EXPERIMENTAL MODEL; FEMALE; GESTATION PERIOD; MALE; NEUROTOXICITY; NONHUMAN; RISK ASSESSMENT; STATISTICAL MODEL;

2,4,5-TRICHLOROPHENOXYACETIC ACID; 2,4-DICHLOROPHENOXYACETIC ACID; ANIMALS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HERBICIDES; HUMANS; LIKELIHOOD FUNCTIONS; MODELS, STATISTICAL; NEUROTOXICITY SYNDROMES; NEUROTOXINS; RATS; RISK; RISK ASSESSMENT; RISK FACTORS;

EID: 11344276215     PISSN: 02724332     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0272-4332.2004.00558.x     Document Type: Article

References (33)

1. Allen, B. C., Kavlock, R. J., Kimmel, C. A., & Faustman, E. M. (1994a). Dose-response assessment for developmental toxicity II: Comparison of generic benchmark dose estimates with no observed adverse effect levels. Fundamental and Applied Toxicology, 23, 487-495.
2. Allen, B. C., Kavlock, R. J., Kimmel, C. A., & Faustman, E. M. (1994b). Dose-response assessment for developmental toxicity II: Statistical models. Fundamental and Applied Toxicology, 23, 496-509.
3. Andersen, H. R., Nielsen, J. B., & Grandjean, P. (2000). Toxicologic evidence of developmental neurotoxicity of environmental chemicals. Toxicology, 144, 121-127.
4. Banks, E. C., Ferretti, L. E., & Shucard, D. W. (1997). Effects of low level lead exposure on cognitive function in children: A review of behavioral neuropsychological and biological evidence. NeuroToxicology, 18, 237-281.
5. Bates, H. K., Cunny, H. S., & Kebede, G. (1997). Developmental neurotoxicity testing methodology. In R. D. Hood (Ed.), Handbook of Developmental Toxicology. Boca Raton, FL: CRC press.
6. Catalano, P. C., Scharfstein, D. O., Ryan, L. M., Kimmel, C. A., & Kimmel, G. L. (1993). Statistical model for fetal death, and malformation in developmental toxicity studies. Teratology. 47, 281-290.
7. Chang, L. W., & Guo, G. L. (1998). Fetal minamata disease-Congenital methylmercury poisoning. In W. L. Slikker & L. W. Chang (Eds.), Handbook of Developmental Neurotoxicology (pp. 507-515). New York: Academic Press.
8. Chen, J. J., Kodell, R. L., & Gaylor, D. W. (1996). Risk assessment for non-quantal toxic effects. In A. M. Fan & L. W. Chang (Eds.), Toxicology and Risk Assessment: Principles, Methods and Applications (pp. 503-513). New York: Marcel Dekker.
9. Claudio, L., Kwa, W. C., Russell, A. L., & Wallinga, D. (2000). Testing methods for developmental neurotoxicity of environmental chemicals. Toxicology and Applied Pharmacology, 164, 1-14.
10. Crump, K. S. (1995). Calculation of benchmark doses from continuous data. Risk Analysis, 15, 79-89.
11. Crump, K. S., & Howe, R. B. (1983). A review of methods for calculating confidence limits on lowdose extrapolation. In D. B. Clayton, D. R. Krewski, & I. C. Monroe (Eds.), Toxicological Risk Assessment (pp. 187-203). Boca Raton, FL: CRC Press.
12. Faustman, E. M., Allen, B. C., Kavlock, R. J., & Kimmel, C. A. (1994). Dose-response assessment for developmental toxicity I. Characterization of database and determination of no observed adverse effect levels. Fundamental and Applied Toxicology, 23, 478-486.
13. Gaylor, D. W. (1992). Incidence of developmental defects at the no observed adverse effect level (NOAEL). Regulatory Toxicology and Pharmacology, 15, 151-160.
14. Gaylor, D. W., & Slikker, W. L. (1990). Risk assessment for neurotoxic effects. NeuroToxicology, 11, 211-218.
15. Gift, J. (2003). EPA's Benchmark Dose Software (BMDS), Version 1.3.2. Available at www.epa.gov/ncea/bmds.htm.
16. Haber, L. T., Allen, B. C., & Kimmel, C. A. (1998). Non-cancer risk assessment for nickel compounds: Issues associated with dose-response modeling of inhalation and oral exposures. Toxicological Sciences, 43, 213-229.
17. Kavlock, R. J., Allen, B. C., Faustman, E. M., & Kimmel, C. A. (1995). Dose-response assessments for developmental toxicity. Fundamental and Applied Toxicology, 26, 211-222.
18. Kimmel, C. A. (1998). Current approaches to risk assessment for developmental neurotoxicity. In W. L. Slikker & L. W. Chang (Eds.), Handbook of Developmental Neurotoxicology (pp. 675-678). New York: Academic Press.
19. Kodell, R. L., Chen, J. J., & Gaylor, D. W. (1995). Neurotoxicity modeling for risk assessment. Regulatory Toxicology and Pharmacology, 22, 24-29.
20. Kodell, R. L., Howe, R. B., Chen, J. J., & Gaylor, D. W. (1991). Mathematical modeling of reproductive and developmental toxic effects for quantitative risk assessment. Risk Analysis, 11, 583-590.
21. Kodell, R. L., & West, R. W. (1993). Upper confidence limits on excess risk for quantitative responses. Risk Analysis, 13, 177-182.
22. Leisenring, W., & Ryan, L. (1992). Statistical properties of the NOAEL. Regulatory Toxicology and Pharmacology, 15, 161-171.
23. Mohammad, F. K., & St. Omer, V. (1985). Developing rat brain monoamine levels following in utero exposure to mixture of 2,4- dichlorophenoxyacetic and 2,4,5-trichlorophenoxyacetic acids. Toxicology Letters, 29, 215-233.
24. Mohammad, F. K., & St. Omer, V. (1986). Behavioral and developmental effects in rats following in utero exposure to 2,4-D/2,4,5-T mixture. Nuerobehavioral Toxicology and Teratology, 8, 551-560.
25. Razzaghi, M., & Kodell, R. L. (2000a). Dose-response modeling for developmental neurotoxicity data. Environmental and Ecological Statistics, 7, 191-203.
26. Razzaghi, M., & Kodell, R. L. (2000b). Risk assessment for quantitative responses using a mixture model. Biometrics, 56, 519-527.
27. Shuey, D. L., Lau, C., Logsdon, T. R., Zucker, R. M., Elstein, K. H., Narotsky, M. G., Setzer, R. W., Kavlock, R. J., & Rogers, J. M. (1994). Biologically based dose-response modeling in developmental toxicology: Biochemical and cellular sequelae of 5-fluorouracil exposure in the developing rat. Toxicology and Applied Pharmacology, 126, 129-144.
28. Slikker, W., & Gaylor, D. W. (1998). Quantitative models of risk assessment for developmental neurotoxicants. In W. Slikker & L. W. Chang (Eds.), Handbook of Developmental Neurotoxicology. New York: Academic Press.
29. Tilson, H. A. (2000). Neurotoxicology risk assessment guidelines. NeuroToxicology, 21, 189-194.
30. Tyl, R. W., Jones-Price, C., Marr, M. C., & Kimmel, C. A. (1983). Teratologic Evaluation of Diethylhexyl Phthalate (CAS No. 111-81-7) in CD-1Mice. Final Study Report for NCTR/NTP Contract No. 222-80-2031 (C), NTIS No. PB85105674. Springfield, VA: National Technical Information Service.
31. U.S. Environmental Protection Agency. (1998a). Health Effects Test Guidelines, OPPTS 8706300. Developmental Neurotoxicity Study, EPA 712-C-98-239.
32. U.S. Environmental Protection Agency. (1991). Guidelines for developmental toxicity risk assessment. Federal Register, 56, 63798-63826.
33. Zhu, Y., & Fung. K. (1996). Statistical methods in developmental toxicity risk assessment. In A. M. Fan & L. W. Chang (Eds.), Toxicology and Risk Assessment: Principles, Methods, and Applications (pp. 413-446). New York: Marcel Dekker.